Abstract:Objective　To observe the effects and safety of rosuvastatin therapy on protecting the renal and heart function in patients with acute coronary syndrome (ACS) combining diabetes mellitus (DM) and concomitant chronic kidney disease (CKD) undergoing contrast media injection. Methods　Concurrent parallel control and before-after self-control method were employed in present study. From Dec. 2008 to Oct. 2011, 2998 patients from 53 central hospitals in China were enrolled in a TRACK-D project. Out of 2998, 2309 patients with ACS combining DM and concomitant CKD were randomly assigned to rosuvastatin group (n=1183) or control group (n=1126). Patients in rosuvastatin group were given rosuvastatin 10mg/d for five days (two days before and three days post-procedure), while those in control group received no treatment. Isotonic non-ionic contrast medium (iodixanol) was used in both groups when angiography, left ventriculography and percutaneous vascular intervention were started. Serum creatinine (Scr), estimated glomerular filtration rate (eGFR) and urinary albumin/creatinine ratio (ACR) were measured before and 48h, 72h after exposure to contrast medium. A 30-day clinical follow-up was conducted including the evaluation of aggravated heart failure, acute renal failure, dialysis/hemofiltration and all-cause mortality. Results　No significant difference existed between the two groups at the preoperative levels of Scr (95.11±23.79μmol/L vs 94.88±20.31μmol/L, P=0.80) and eGFR [73.98±14.52ml/(min.1.73m2) vs 74.10±13.80ml/(min.1.73m2), P=0.85]. The postoperative Scr level showed no significant difference between the two groups (94.87±25.15μmol/L vs 95.74±30.50μmol/L, P=0.45), however, the postoperative Scr value presented a decline tendency in rosuvastatin group, while an upward trend in control group. The 30-day clinical follow-up found that the incidence of aggravated heart failure was significantly lower in rosuvastatin group than in control group (2.4% vs 4.2%; P=0.025). Conclusions　Perioperative short-term rosuvastatin therapy may have a certain protective effect on renal function of ACS patients with DM and concomitant CKD, and reduce the postoperative cardiovascular events. DOI: 10.11855/j.issn.0577-7402.2014.07.07

Clinical study of Rosuvastatin in the treatment of diastolic heart failure

Clinical Study for Dose-Effect and Safety of Rosuvastatin in Patients with Primary Hypercholesterolemia

Rosuvastatin-attenuated heart failure in aged spontaneously hypertensive rats via PKCα/β2 signal pathway.

Beneficial effect of rosuvastatin on cardiac dysfunction is associated with alterations in calcium-regulatory proteins.

Effect of statin on improves cardiac diastolic function and reduces exercise B-type natriuretic peptide level

Effects of Pravastatin on Cardiac Function and Plasma Level of Brain Natriuretic Peptide in Patients with Chronic Heart Failure

Effect of Rosuvastatin in Patients with Chronic Congestive Heart Failure

Effects of Different Doses of Rosuvastatin on High-sensitivity C-reactive Protein(hs-CRP) and Interleukin-6 (IL-6) in Patients with Acute Coronary Syndrome.

Effect of atorvastatin on exercise tolerance in patients with diastolic dysfunction and exercise-induced hypertension

Effect of atorvastatin on decreasing a hypertensive response to exercise and improving exercise tolerance

Rosuvastatin Reverses Hypertension-Induced Changes in the Aorta Structure and Endothelium-Dependent Relaxation in Rats Through Suppression of Apoptosis and Inflammation.

Effect of Rosuvastatin on the Heart Function of Patients with Ischemic Cardiomyopathy

Effect of Rosuvastatin on the Change of Th1/Th2 Subsets in Coronary Heart Disease with Diabetes

[Influence of fluvastatin on left ventricular remodeling after myocardial infarction in rats].

Protective effects and the mechanism of Rosuvastatin on type 2 diabetic rats

Clinical study on the effect and security of different doses of rosuvastatin therapy in acute coronary syndrome ;patients with diabetes

Effects of short-term rosuvastatin therapy on heart and kidney function in patients with acute coronary syndrome combining diabetes mellitus and concomitant chronic kidney disease

The Effects of Atorvastatin and Rosuvastatin on Exercise Tolerance in Patients with Coronary Heart Disease

Effect of atorvastatin on level of B-type natriuretic peptide and cardiac function in patients with coronary heart disease and heart failure

Effects of Rosuvastatin on Inflammatory Factors and Adiponectin in Patients with Acute Myocardial Infarction

Effects of statin treatment on cardiac function in patients with chronic heart failure: a meta-analysis of randomized controlled trials.